Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040536 | SCV000064227 | uncertain significance | not specified | 2013-03-11 | criteria provided, single submitter | clinical testing | The Ser20193Phe variant in TTN has not been reported in the literature, but has been previously identified by our laboratory in 1 individual with HCM who carrie d a likely pathogenic variant in another gene (LMM unpublished data). This varia nt has also not been identified in large European American and African American populations by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/ EVS), though it may be present in other populations. Serine (Ser) at position 20 193 is not conserved in mammals, suggesting that a change at this position may b e tolerated. Additional computational analyses (biochemical amino acid propertie s, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. In summary, additional information is needed to fully assess the clinical significance of the Ser20193Phe variant. |